Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Uncovering the mouse olfactory long non-coding transcriptome with a novel machine-learning model.

Camargo AP, Nakahara TS, Firmino LER, Netto PHM, do Nascimento JBP, Donnard ER, Galante PAF, Carazzolle MF, Malnic B, Papes F.

DNA Res. 2019 Aug 1;26(4):365-378. doi: 10.1093/dnares/dsz015.

2.

Retroposed copies of RET gene: a somatically acquired event in medullary thyroid carcinoma.

Bim LV, Navarro FCP, Valente FOF, Lima-Junior JV, Delcelo R, Dias-da-Silva MR, Maciel RMB, Galante PAF, Cerutti JM.

BMC Med Genomics. 2019 Jul 9;12(1):104. doi: 10.1186/s12920-019-0552-1.

3.

Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development.

Velasco MX, Kosti A, Guardia GDA, Santos MC, Tegge A, Qiao M, Correa BRS, Hernández G, Kokovay E, Galante PAF, Penalva LOF.

RNA. 2019 Jul;25(7):768-782. doi: 10.1261/rna.069211.118. Epub 2019 Apr 19.

PMID:
31004009
4.

Transposon insertion profiling by sequencing (TIPseq) for mapping LINE-1 insertions in the human genome.

Steranka JP, Tang Z, Grivainis M, Huang CRL, Payer LM, Rego FOR, Miller TLA, Galante PAF, Ramaswami S, Heguy A, Fenyö D, Boeke JD, Burns KH.

Mob DNA. 2019 Mar 8;10:8. doi: 10.1186/s13100-019-0148-5. eCollection 2019.

5.

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease.

Dos Santos MCT, Barreto-Sanz MA, Correia BRS, Bell R, Widnall C, Perez LT, Berteau C, Schulte C, Scheller D, Berg D, Maetzler W, Galante PAF, Nogueira da Costa A.

Oncotarget. 2018 Apr 3;9(25):17455-17465. doi: 10.18632/oncotarget.24736. eCollection 2018 Apr 3.

6.

Histopathological Characterization and Whole Exome Sequencing of Ectopic Thyroid: Fetal Architecture in a Functional Ectopic Gland from Adult Patient.

Camargo RY, Kanamura CT, Friguglietti CU, Nogueira CR, Iorcansky S, Tincani AJ, Bezerra AK, Brust E, Koyama FC, Camargo AA, Rego FOR, Galante PAF, Medeiros-Neto G, Rubio IGS.

Int J Endocrinol. 2018 Feb 8;2018:4682876. doi: 10.1155/2018/4682876. eCollection 2018.

7.

Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity.

Correa BRS, Hu J, Penalva LOF, Schlegel R, Rimm DL, Galante PAF, Agarwal S.

Sci Rep. 2018 Mar 6;8(1):4097. doi: 10.1038/s41598-018-22427-1.

8.

Identification and Validation of Potential Differential miRNA Regulation via Alternative Polyadenylation.

Hübner M, Galante PAF, Kreth S, Hinske LC.

Methods Mol Biol. 2018;1733:87-92. doi: 10.1007/978-1-4939-7601-0_7.

PMID:
29435925
9.

MiRIAD update: using alternative polyadenylation, protein interaction network analysis and additional species to enhance exploration of the role of intragenic miRNAs and their host genes.

Hinske LC, Dos Santos FRC, Ohara DT, Ohno-Machado L, Kreth S, Galante PAF.

Database (Oxford). 2017 Jan 1;2017. doi: 10.1093/database/bax053.

10.

A straightforward assay to evaluate DNA integrity and optimize next-generation sequencing for clinical diagnosis in oncology.

Bettoni F, Koyama FC, de Avelar Carpinetti P, Galante PAF, Camargo AA, Asprino PF.

Exp Mol Pathol. 2017 Dec;103(3):294-299. doi: 10.1016/j.yexmp.2017.11.011. Epub 2017 Nov 21.

11.

TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias.

Asprino PF, Linck RDM, Cesar J, Freitas FP, Koyama FC, Riechelmann RSP, Costa FP, Hoff PMG, Galante PAF, Meyer D, Camargo AA, Sabbaga J.

Endocr Relat Cancer. 2018 Feb;25(2):L1-L5. doi: 10.1530/ERC-17-0286. Epub 2017 Nov 22. No abstract available.

12.

Measuring plasma levels of three microRNAs can improve the accuracy for identification of malignant breast lesions in women with BI-RADS 4 mammography.

Pezuk JA, Miller TLA, Bevilacqua JLB, de Barros ACSD, de Andrade FEM, E Macedo LFA, Aguilar V, Claro ANM, Camargo AA, Galante PAF, Reis LFL.

Oncotarget. 2017 Sep 11;8(48):83940-83948. doi: 10.18632/oncotarget.20806. eCollection 2017 Oct 13.

13.

MRPL53, a New Candidate Gene for Orofacial Clefting, Identified Using an eQTL Approach.

Masotti C, Brito LA, Nica AC, Ludwig KU, Nunes K, Savastano CP, Malcher C, Ferreira SG, Kobayashi GS, Bueno DF, Alonso N, Franco D, Rojas-Martinez A, Dos Santos SE, Galante PA, Meyer D, Hünemeier T, Mangold E, Dermitzakis ET, Passos-Bueno MR.

J Dent Res. 2018 Jan;97(1):33-40. doi: 10.1177/0022034517735805. Epub 2017 Oct 20.

PMID:
29053389
14.

Unveiling the Impact of the Genomic Architecture on the Evolution of Vertebrate microRNAs.

França GS, Hinske LC, Galante PA, Vibranovski MD.

Front Genet. 2017 Mar 21;8:34. doi: 10.3389/fgene.2017.00034. eCollection 2017. Review.

15.

Signaling transcript profile of the asexual intraerythrocytic development cycle of Plasmodium falciparum induced by melatonin and cAMP.

Lima WR, Tessarin-Almeida G, Rozanski A, Parreira KS, Moraes MS, Martins DC, Hashimoto RF, Galante PAF, Garcia CRS.

Genes Cancer. 2016 Sep;7(9-10):323-339. doi: 10.18632/genesandcancer.118.

16.

A genetic cluster of patients with variant xeroderma pigmentosum with two different founder mutations.

Munford V, Castro LP, Souto R, Lerner LK, Vilar JB, Quayle C, Asif H, Schuch AP, de Souza TA, Ienne S, Alves FIA, Moura LMS, Galante PAF, Camargo AA, Liboredo R, Pena SDJ, Sarasin A, Chaibub SC, Menck CFM.

Br J Dermatol. 2017 May;176(5):1270-1278. doi: 10.1111/bjd.15084. Epub 2017 Mar 22.

PMID:
27664908
17.

Intratumoral Genetic Heterogeneity in Rectal Cancer: Are Single Biopsies representative of the entirety of the tumor?

Bettoni F, Masotti C, Habr-Gama A, Correa BR, Gama-Rodrigues J, Vianna MR, Vailati BB, São Julião GP, Fernandez LM, Galante PA, Camargo AA, Perez RO.

Ann Surg. 2017 Jan;265(1):e4-e6. doi: 10.1097/SLA.0000000000001937.

PMID:
27479130
18.

Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.

Correa BR, de Araujo PR, Qiao M, Burns SC, Chen C, Schlegel R, Agarwal S, Galante PA, Penalva LO.

Genome Biol. 2016 Jun 10;17(1):125. doi: 10.1186/s13059-016-0990-4.

19.

Host gene constraints and genomic context impact the expression and evolution of human microRNAs.

França GS, Vibranovski MD, Galante PA.

Nat Commun. 2016 Apr 25;7:11438. doi: 10.1038/ncomms11438.

20.

MicroRNA Expression Signature Is Altered in the Cardiac Remodeling Induced by High Fat Diets.

Guedes EC, França GS, Lino CA, Koyama FC, Moreira Ldo N, Alexandre JG, Barreto-Chaves ML, Galante PA, Diniz GP.

J Cell Physiol. 2016 Aug;231(8):1771-83. doi: 10.1002/jcp.25280. Epub 2015 Dec 30.

PMID:
26638879
21.

The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.

Carpinetti P, Donnard E, Bettoni F, Asprino P, Koyama F, Rozanski A, Sabbaga J, Habr-Gama A, Parmigiani RB, Galante PA, Perez RO, Camargo AA.

Oncotarget. 2015 Nov 10;6(35):38360-71. doi: 10.18632/oncotarget.5256.

22.

Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice.

Campesato LF, Barroso-Sousa R, Jimenez L, Correa BR, Sabbaga J, Hoff PM, Reis LF, Galante PA, Camargo AA.

Oncotarget. 2015 Oct 27;6(33):34221-7. doi: 10.18632/oncotarget.5950.

23.

A Mouse Model of Targeted Musashi1 Expression in Whole Intestinal Epithelium Suggests Regulatory Roles in Cell Cycle and Stemness.

Cambuli FM, Correa BR, Rezza A, Burns SC, Qiao M, Uren PJ, Kress E, Boussouar A, Galante PA, Penalva LO, Plateroti M.

Stem Cells. 2015 Dec;33(12):3621-34. doi: 10.1002/stem.2202. Epub 2015 Sep 26.

24.

A Genome-Wide Landscape of Retrocopies in Primate Genomes.

Navarro FC, Galante PA.

Genome Biol Evol. 2015 Jul 29;7(8):2265-75. doi: 10.1093/gbe/evv142.

25.

Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.

Lopes-Ramos C, Koyama FC, Habr-Gama A, Salim AC, Bettoni F, Asprino PF, França GS, Gama-Rodrigues J, Parmigiani RB, Perez RO, Galante PA, Camargo AA.

Cancer Genet. 2015 Jun;208(6):319-26. doi: 10.1016/j.cancergen.2015.03.010. Epub 2015 Mar 25.

PMID:
25963525
26.

Alternative polyadenylation allows differential negative feedback of human miRNA miR-579 on its host gene ZFR.

Hinske LC, Galante PA, Limbeck E, Möhnle P, Parmigiani RB, Ohno-Machado L, Camargo AA, Kreth S.

PLoS One. 2015 Mar 23;10(3):e0121507. doi: 10.1371/journal.pone.0121507. eCollection 2015.

27.

Identification of agonists for a group of human odorant receptors.

Gonzalez-Kristeller DC, do Nascimento JB, Galante PA, Malnic B.

Front Pharmacol. 2015 Mar 3;6:35. doi: 10.3389/fphar.2015.00035. eCollection 2015.

28.

ICRmax: an optimized approach to detect tumor-specific interchromosomal rearrangements for clinical application.

Donnard ER, Carpinetti PA, Navarro FC, Perez RO, Habr-Gama A, Parmigiani RB, Camargo AA, Galante PA.

Genomics. 2015 May;105(5-6):265-72. doi: 10.1016/j.ygeno.2015.01.009. Epub 2015 Feb 7.

29.

Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.

Lopes-Ramos CM, Habr-Gama A, Quevedo Bde S, Felício NM, Bettoni F, Koyama FC, Asprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, Perez RO, Parmigiani RB.

BMC Med Genomics. 2014 Dec 11;7:68. doi: 10.1186/s12920-014-0068-7.

30.

miRIAD-integrating microRNA inter- and intragenic data.

Hinske LC, França GS, Torres HA, Ohara DT, Lopes-Ramos CM, Heyn J, Reis LF, Ohno-Machado L, Kreth S, Galante PA.

Database (Oxford). 2014 Oct 6;2014. pii: bau099. doi: 10.1093/database/bau099. Print 2014.

31.

Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy.

Donnard E, Asprino PF, Correa BR, Bettoni F, Koyama FC, Navarro FC, Perez RO, Mariadason J, Sieber OM, Strausberg RL, Simpson AJ, Jardim DL, Reis LF, Parmigiani RB, Galante PA, Camargo AA.

Oncotarget. 2014 Oct 15;5(19):9199-213.

32.

Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour.

Torrezan GT, Ferreira EN, Nakahata AM, Barros BD, Castro MT, Correa BR, Krepischi AC, Olivieri EH, Cunha IW, Tabori U, Grundy PE, Costa CM, de Camargo B, Galante PA, Carraro DM.

Nat Commun. 2014 Jun 9;5:4039. doi: 10.1038/ncomms5039.

33.

The human cell surfaceome of breast tumors.

da Cunha JP, Galante PA, de Souza JE, Pieprzyk M, Carraro DM, Old LJ, Camargo AA, de Souza SJ.

Biomed Res Int. 2013;2013:976816. doi: 10.1155/2013/976816. Epub 2013 Sep 9.

34.

RCPedia: a database of retrocopied genes.

Navarro FC, Galante PA.

Bioinformatics. 2013 May 1;29(9):1235-7. doi: 10.1093/bioinformatics/btt104. Epub 2013 Mar 1.

35.

SurfaceomeDB: a cancer-orientated database for genes encoding cell surface proteins.

de Souza JE, Galante PA, de Almeida RV, da Cunha JP, Ohara DT, Ohno-Machado L, Old LJ, de Souza SJ.

Cancer Immun. 2012;12:15. Epub 2012 Dec 28.

36.

Gene copy-number polymorphism caused by retrotransposition in humans.

Schrider DR, Navarro FC, Galante PA, Parmigiani RB, Camargo AA, Hahn MW, de Souza SJ.

PLoS Genet. 2013;9(1):e1003242. doi: 10.1371/journal.pgen.1003242. Epub 2013 Jan 24.

37.

SPLOOCE: a new portal for the analysis of human splicing variants.

Kroll JE, Galante PA, Ohara DT, Navarro FC, Ohno-Machado L, de Souza SJ.

RNA Biol. 2012 Nov;9(11):1339-43. doi: 10.4161/rna.22182. Epub 2012 Oct 12.

38.

Setting up an intronic miRNA database.

Hinske LC, Heyn J, Galante PA, Ohno-Machado L, Kreth S.

Methods Mol Biol. 2013;936:69-76.

PMID:
23007499
39.

Common promoter elements in odorant and vomeronasal receptor genes.

Michaloski JS, Galante PA, Nagai MH, Armelin-Correa L, Chien MS, Matsunami H, Malnic B.

PLoS One. 2011;6(12):e29065. doi: 10.1371/journal.pone.0029065. Epub 2011 Dec 28.

40.

Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.

Maschietto M, Trapé AP, Piccoli FS, Ricca TI, Dias AA, Coudry RA, Galante PA, Torres C, Fahhan L, Lourenço S, Grundy PE, de Camargo B, de Souza S, Neves EJ, Soares FA, Brentani H, Carraro DM.

Cell Death Dis. 2011 Nov 3;2:e224. doi: 10.1038/cddis.2011.105.

41.

Distinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individual.

Galante PA, Parmigiani RB, Zhao Q, Caballero OL, de Souza JE, Navarro FC, Gerber AL, Nicolás MF, Salim AC, Silva AP, Edsall L, Devalle S, Almeida LG, Ye Z, Kuan S, Pinheiro DG, Tojal I, Pedigoni RG, de Sousa RG, Oliveira TY, de Paula MG, Ohno-Machado L, Kirkness EF, Levy S, da Silva WA Jr, Vasconcelos AT, Ren B, Zago MA, Strausberg RL, Simpson AJ, de Souza SJ, Camargo AA.

Nucleic Acids Res. 2011 Aug;39(14):6056-68. doi: 10.1093/nar/gkr221. Epub 2011 Apr 14.

42.

Alternative splicing and genetic diversity: silencers are more frequently modified by SNVs associated with alternative exon/intron borders.

de Souza JE, Ramalho RF, Galante PA, Meyer D, de Souza SJ.

Nucleic Acids Res. 2011 Jul;39(12):4942-8. doi: 10.1093/nar/gkr081. Epub 2011 Mar 11.

43.

PositionMatcher: A Fast Custom-Annotation Tool for Short DNA Sequences.

Pitzer E, Kim J, Patel K, Galante PA, Ohno-Machado L.

Summit Transl Bioinform. 2010 Mar 1;2010:25-9.

44.

Analysis of allelic differential expression in the human genome using allele-specific serial analysis of gene expression tags.

Vidal DO, de Souza JE, Pires LC, Masotti C, Salim AC, Costa MC, Galante PA, de Souza SJ, Camargo AA.

Genome. 2011 Feb;54(2):120-7. doi: 10.1139/G10-103.

PMID:
21326368
45.

Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing.

Zhao Q, Kirkness EF, Caballero OL, Galante PA, Parmigiani RB, Edsall L, Kuan S, Ye Z, Levy S, Vasconcelos AT, Ren B, de Souza SJ, Camargo AA, Simpson AJ, Strausberg RL.

Genome Biol. 2010;11(11):R114. doi: 10.1186/gb-2010-11-11-r114. Epub 2010 Nov 25.

46.

PVALB, a new Hürthle adenoma diagnostic marker identified through gene expression.

Cerutti JM, Oler G, Delcelo R, Gerardt R, Michaluart P Jr, de Souza SJ, Galante PA, Huang P, Riggins GJ.

J Clin Endocrinol Metab. 2011 Jan;96(1):E151-60. doi: 10.1210/jc.2010-1318. Epub 2010 Oct 6.

47.

A potential role for intragenic miRNAs on their hosts' interactome.

Hinske LC, Galante PA, Kuo WP, Ohno-Machado L.

BMC Genomics. 2010 Oct 1;11:533. doi: 10.1186/1471-2164-11-533.

48.

Bioinformatics construction of the human cell surfaceome.

da Cunha JP, Galante PA, de Souza JE, de Souza RF, Carvalho PM, Ohara DT, Moura RP, Oba-Shinja SM, Marie SK, Silva WA Jr, Perez RO, Stransky B, Pieprzyk M, Moore J, Caballero O, Gama-Rodrigues J, Habr-Gama A, Kuo WP, Simpson AJ, Camargo AA, Old LJ, de Souza SJ.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16752-7. doi: 10.1073/pnas.0907939106. Epub 2009 Sep 15.

49.

Towards large-scale sample annotation in gene expression repositories.

Pitzer E, Lacson R, Hinske C, Kim J, Galante PA, Ohno-Machado L.

BMC Bioinformatics. 2009 Sep 17;10 Suppl 9:S9. doi: 10.1186/1471-2105-10-S9-S9.

50.

Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis.

Bettoni F, Filho FC, Grosso DM, Galante PA, Parmigiani RB, Geraldo MV, Henrique-Silva F, Oba-Shinjo SM, Marie SK, Soares FA, Brentani HP, Simpson AJ, de Souza SJ, Camargo AA.

Genomics. 2009 Sep;94(3):153-60. doi: 10.1016/j.ygeno.2009.06.001. Epub 2009 Jun 18.

Supplemental Content

Loading ...
Support Center